Skip to main content
Lizet E. van der Kolk on Muck Rack

Lizet E. van der Kolk

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Lizet E.

Contact Lizet E., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Author Correction: Real-world clinical utility of tumor whole-genome sequencing in solid cancers

|
By Jeffrey van Putten, Petur Snaebjornsson, Linda J. W. Bosch, Roelof Koster, Paul Roepman, Joseph Usset, Mirjam C. Boelens, Tom van Wezel, Efraim H Rosenberg, Serena Marchetti, Marieke Vollebergh, Doenja M. J. Lambregts, Lizet E. van der Kolk, Edwin Cuppen, Hilde H. Nienhuis, Kim Monkhorst
| Nature Verified
Correction to: Nature Medicine https://doi.org/10.1038/s41591-026-04280-2, published online 20 March 2026. In the version of this article initially published, due to a version error, values listed on the right-hand side of Fig.
Open in Who Shared Issue with article?

Real-world clinical utility of tumor whole-genome sequencing in solid cancers

|
By Petur Snaebjornsson, Roelof Koster, Paul Roepman, Joseph Usset, Mirjam C. Boelens, Tom van Wezel, Efraim H Rosenberg, Serena Marchetti, Marieke Vollebergh, Edwin Cuppen, Kim Monkhorst, Jeffrey van Putten, Linda J. W. Bosch, Doenja M. J. Lambregts, Lizet E. van der Kolk, Hilde H. Nienhuis
| Nature Verified
Abstract Molecular testing is essential in precision oncology. Whole-genome sequencing (WGS) provides a tumor-agnostic solution for detecting an increasingly complex range of DNA-based biomarkers. Here we present real-world data from 888 patients to demonstrate the clinical utility of routine, paired tumor-normal WGS diagnostics for solid cancers in a comprehensive cancer center. WGS succeeded in 89% of cases with a median turnaround time of 6 working days.
Open in Who Shared Issue with article?
See all 2 articles